Physician profile
Samual Todd
NPI 1104858281
$1,020.98
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $759 · 2020: $29.99 · 2022: $49.57 · 2023: $47.89 · 2024: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $182.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $242.09 | 2019 | |
| Portola Pharmaceuticals, LLC | $194.58 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $182.89 | 2023-2024 | |
| Z-Medica, LLC | $181.65 | 2019 | |
| Prytime Medical Devices, INC. | $61.83 | 2019-2020 | |
| Pfizer INC. | $31.96 | 2019 | |
| Teleflex LLC | $27.49 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $25.06 | 2019 | |
| Atricure, INC. | $22.08 | 2022 | |
| Acell, INC. | $20.47 | 2019 | |
| Smith+Nephew, INC. | $18.74 | 2019 | |
| Tela Bio, INC. | $12.14 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samual Todd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.